Abstract
Cancer is a worldwide health problem with various genetic and epigenetic alterations, resulting in disease heterogeneity. Effective diagnostic, therapeutic, and monitoring markers have been determined recently; however, new diagnostic, prognostic, and therapeutic markers are needed. MicroRNAs (miRNA), short non-coding RNAs, have a highlighted role in cancer progression, migration, and programmed cell death. Our study aims to investigate the significance of miR-125a-3p and its downstream targets in breast (BRCA), hepatocellular (HCC), and ovarian (OVCA) malignancies and their possibility as diagnostic biomarkers and targets for therapeutic agents. Bioinformatics and online tools were used to determine the miRNA-predicted downstream targets, analyze GEO datasets, and perform functional annotation of the miRNA-target genes. We tested the levels of miR-125a-3p and its targeted genes expression in SKOV-3, Hep G2, and MCF-7 cell lines in addition to ovarian cancer tissue samples and SKOV-3 treated with paclitaxel (PTX) using qPCR. Combining the in silico and in vitro analyses, miR-125a-3p was significantly downregulated in BRCA, OVCA and HCC. At the same time, it was significantly elevated in the ovarian cancer tissue samples obtained from pre-treated patients, indicating that miR-125a-3p is an oncosuppressor miRNA. Our in silico analysis determined BOK and ARHGEF39 as potential downstream targets of miR-125a-3p. BOK was significantly downregulated in BRCA and HCC cancers; on the contrary, its expression was raised in OVCA. It was also upregulated in OVCA pre-treated samples and cell lines. ARHGEF39 was significantly upregulated in BRCA, HCC, and OVCA and downregulated in pre-treated OVCA samples and cell lines. Finally, our findings suggest miR-125a-3p, BOK, and ARHGEF39 could serve as possible diagnostic and monitoring biomarkers as well as therapeutic targets for cancer treatment.
School
School of Sciences and Engineering
Department
Biotechnology Program
Degree Name
MS in Biotechnology
Graduation Date
Winter 2-19-2025
Submission Date
1-28-2025
First Advisor
Asma Amleh
Committee Member 1
Ahmed Abdellatif
Committee Member 2
Khaled Abou Aisha
Extent
74 p.
Document Type
Master's Thesis
Institutional Review Board (IRB) Approval
Approval has been obtained for this item
Recommended Citation
APA Citation
Anwer, E. K.
(2025).MiR-125a-3p and its Targets: Promising Biomarkers for Ovarian, Liver, and Breast Cancers, Offering a Beacon of Hope for More Effective Diagnosis and Treatment Strategies [Master's Thesis, the American University in Cairo]. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/2471
MLA Citation
Anwer, Eman Kamaleldien. MiR-125a-3p and its Targets: Promising Biomarkers for Ovarian, Liver, and Breast Cancers, Offering a Beacon of Hope for More Effective Diagnosis and Treatment Strategies. 2025. American University in Cairo, Master's Thesis. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/2471
Included in
Medical Biotechnology Commons, Medical Cell Biology Commons, Medical Genetics Commons, Medical Molecular Biology Commons, Neoplasms Commons